1443 related articles for article (PubMed ID: 25488030)
1. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Lees AJ; Tolosa E; Olanow CW
Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
[TBL] [Abstract][Full Text] [Related]
2. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
Fahn S
Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
[TBL] [Abstract][Full Text] [Related]
3. The L-DOPA story revisited. Further surprises to be expected?
Foley P
J Neural Transm Suppl; 2000; (60):1-20. PubMed ID: 11205132
[TBL] [Abstract][Full Text] [Related]
4. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.
Fahn S
Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S1-S5. PubMed ID: 28784297
[TBL] [Abstract][Full Text] [Related]
5. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
6. Levodopa therapy for Parkinson disease: A look backward and forward.
LeWitt PA; Fahn S
Neurology; 2016 Apr; 86(14 Suppl 1):S3-12. PubMed ID: 27044648
[TBL] [Abstract][Full Text] [Related]
7. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
Hornykiewicz O
Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
[TBL] [Abstract][Full Text] [Related]
8. [Short history of L-Dopa].
García Ruiz PJ; Meseguer E
Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
[TBL] [Abstract][Full Text] [Related]
9. The Story of Levodopa: A Long and Arduous Journey.
Bhattacharyya KB
Ann Indian Acad Neurol; 2022; 25(1):124-130. PubMed ID: 35342258
[TBL] [Abstract][Full Text] [Related]
10. History of levodopa and dopamine agonists in Parkinson's disease treatment.
Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
[TBL] [Abstract][Full Text] [Related]
11. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Fahn S;
J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
[TBL] [Abstract][Full Text] [Related]
12. Professor Oleh Hornykiewicz on the occasion of his 75th birthday and the first L-DOPA treatment of Parkinson's disease 40 years ago.
Kobinger W
Wien Klin Wochenschr; 2001 Nov; 113(22):847-50. PubMed ID: 11762120
[No Abstract] [Full Text] [Related]
13. Oleh Hornykiewicz (1926-2020): Sixty Years since the Pioneering L-DOPA Application - One Year since the Death of the Pioneer.
Ibrahimagić OĆ; Tadić A; Kunić S; Smajlović D; Dostović Z; Iljazović A
Psychiatr Danub; 2021; 33(Suppl 4):1204-1209. PubMed ID: 35354188
[TBL] [Abstract][Full Text] [Related]
14. Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives.
Bogetofte H; Alamyar A; Blaabjerg M; Meyer M
CNS Neurol Disord Drug Targets; 2020; 19(8):572-583. PubMed ID: 32703142
[TBL] [Abstract][Full Text] [Related]
15. Classics in chemical neuroscience: levodopa.
Whitfield AC; Moore BT; Daniels RN
ACS Chem Neurosci; 2014 Dec; 5(12):1192-7. PubMed ID: 25270271
[TBL] [Abstract][Full Text] [Related]
16. L-dopa therapy for Parkinson's disease: past, present, and future.
Nagatsua T; Sawadab M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S3-8. PubMed ID: 19131039
[TBL] [Abstract][Full Text] [Related]
17. Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa.
Kim HJ; Jeon BS; Jenner P
Int Rev Neurobiol; 2017; 132():295-343. PubMed ID: 28554412
[TBL] [Abstract][Full Text] [Related]
18. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
19. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
20. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.
LeWitt PA
Mov Disord; 2015 Jan; 30(1):64-72. PubMed ID: 25449210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
